Trial Profile
Selection of Chemoradiotherapy Based on Response to Induction Chemotherapy - a Phase II Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck.
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 11 May 2020
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Cetuximab; Cisplatin; Fluorouracil; Hydroxycarbamide; Paclitaxel
- Indications Head and neck cancer; Hypopharyngeal cancer; Nasopharyngeal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 29 Apr 2020 Status changed from active, no longer recruiting to discontinued.
- 09 Oct 2017 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.
- 09 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Aug 2018.